|Blood transfusions are playing an important role to support the cutting-edge therapies. And the blood supply becomes safer than ever before. However, some risks still exist despite many improvements in viral detections.
We are pleased to introduce INTERCEPT Blood System, an innovative and unique system to inactivate pathogens and lymphocytes in blood products, developed by Cerus Corporation.
BioOne will offer you the integrated solution to take next step for safer blood supply in East Asia Countries.